Peer-reviewedCC BY 4.0mSphere
Accelerating research to keep pace with the rising incidence of coccidioidomycosis
- 1Division of Infectious Diseases, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA
- 2Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon, USA
Abstract
The number of infections caused by the fungal pathogen Coccidioides is rising. In tandem, the number and breadth of researchers studying this important dimorphic fungal pathogen are growing as well. This review focuses on recent advances in the field and identifies areas primed for ongoing rapid growth, with the goal to improve treatments for coccidioidomycosis as soon as reasonably possible. These areas include building genetic tools, high-throughput drug screening, developing immunomodulatory therapies for coccidioidomycosis, and incorporating research methodologies that can be performed outside of the biosafety level 3 laboratory.
Related
- National incidence of coccidioidomycosis in the United States estimated through machine learning integration of epidemiological, veterinary, and socioecological data
- Evolution and main causes of the rising legionellosis incidence in the United States
- Research Preparedness Among Osteopathic Medical Students in the Post-Pass/Fail Licensing Examination Era: Bridging the Gap Between Rising Expectations and Student Confidence
- Accelerating equitable cancer genomics and precision oncology in health care and research: a Lancet Oncology Commission
- Disseminated Pulmonary Coccidioidomycosis Presenting as a Wedge-Shaped Necrotic Mass Mimicking Malignancy
BibTeX
@article{homer2026accelerating,
title = {{Accelerating research to keep pace with the rising incidence of coccidioidomycosis}},
author = {Christina M. Homer},
journal = {mSphere},
year = {2026},
month = sep,
doi = {10.1128/msphere.00082-26},
url = {https://doi.org/10.1128/msphere.00082-26},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Accelerating research to keep pace with the rising incidence of coccidioidomycosis
AU - Christina M. Homer
PY - 2026
DA - 2026/09/25
JO - mSphere
DO - 10.1128/msphere.00082-26
UR - https://doi.org/10.1128/msphere.00082-26
AB - The number of infections caused by the fungal pathogen Coccidioides is rising. In tandem, the number and breadth of researchers studying this important dimorphic fungal pathogen are growing as well. This review focuses on recent advances in the field and identifies areas primed for ongoing rapid growth, with the goal to improve treatments for coccidioidomycosis as soon as reasonably possible. These areas include building genetic tools, high-throughput drug screening, developing immunomodulatory therapies for coccidioidomycosis, and incorporating research methodologies that can be performed outside of the biosafety level 3 laboratory.
SN - 2379-5042
ER -